Joint

First Phosphate and Integrals Power sign Joint Development Agreement to Produce Environmentally Compliant Battery Grade Iron III Phosphate Precursor for the LFP Battery Industry

Retrieved on: 
Thursday, February 15, 2024
Iron(III) phosphate, Research, USD, OTC, Phosphate, LFP, Lithium carbonate, Joint, Saguenay, IPL

Iron phosphate is a manufactured substance used as a base precursor in the traditional production of LFP cathode active material ("CAM") in China.

Key Points: 
  • Iron phosphate is a manufactured substance used as a base precursor in the traditional production of LFP cathode active material ("CAM") in China.
  • Iron phosphate is generally produced in China using iron sulfate and mono ammonium phosphate.
  • A new process for making iron phosphate precursor is required for the European and North American LFP battery industry, one which is compliant with applicable environmental standards.
  • The parties agree to undertake an initial phase of joint development of the technology needed to produce the iron phosphate precursor for LFP CAM.

AllSurplus to Conduct Online Auction of Unused Surplus Line Pipe for Leading Energy Company

Retrieved on: 
Thursday, February 15, 2024
Partial, EST, Joint, Coorilose Geevarghese, Liquidity Services

BETHESDA, Md., Feb. 15, 2024 (GLOBE NEWSWIRE) -- Liquidity Services (NASDAQ: LQDT), a leading global commerce company powering the circular economy, today announced the auction of energy surplus assets in Channelview, Texas for an American multinational energy partner.

Key Points: 
  • BETHESDA, Md., Feb. 15, 2024 (GLOBE NEWSWIRE) -- Liquidity Services (NASDAQ: LQDT), a leading global commerce company powering the circular economy, today announced the auction of energy surplus assets in Channelview, Texas for an American multinational energy partner.
  • More than 1,400 unused joints of subsea flowline, risers and heavy wall line pipe are currently available until 2:00 pm EST February 29, 2024 on AllSurplus.com , the largest online marketplace for surplus business assets.
  • “As energy projects come to completion, unused surplus material presents an opportunity for offshore operators, pipeline companies, and their engineering/construction service providers.
  • This event features unused pipe, some coated, some bare, ready for purchase and pick-up.

Groundbreaking Innovation in Musculoskeletal Healthcare Takes Center Stage at AAOS 2024 Annual Meeting: CytexOrtho Named OrthoPitch Technology Competition Winner

Retrieved on: 
Wednesday, February 14, 2024
Multi-monitor, SAN, Committee, Doctor of Philosophy, DBT, MD, Physician, FDA, Surgeon, Cell, Biopharmaceutical, Therapy, Joint, Health, Patient, Clinical trial, Medicine, MCRA, AAOS, American Academy, Medical device

SAN FRANCISCO, Feb. 14, 2024 /PRNewswire/ -- The American Academy of Orthopaedic Surgeons (AAOS) named CytexOrtho the winner of the inaugural OrthoPitch Technology Competition during the AAOS 2024 Annual Meeting in San Francisco.

Key Points: 
  • SAN FRANCISCO, Feb. 14, 2024 /PRNewswire/ -- The American Academy of Orthopaedic Surgeons (AAOS) named CytexOrtho the winner of the inaugural OrthoPitch Technology Competition during the AAOS 2024 Annual Meeting in San Francisco.
  • Through the competition, the AAOS, the world's largest medical association of musculoskeletal specialists, aims to fuel innovation and foster advancements with the potential to improve or transform existing standards of orthopaedic care.
  • "Being named winner of the first OrthoPitch competition validates the hard work our team at CytexOrtho has devoted to helping patients through this technology," Dr. Estes said.
  • Ultimately, CytexOrtho was named the winner, impressing both the judges and audience, which contributed to the outcome via a live online vote.

The Institutes Griffith Foundation Welcomes New Advisory Council Members, Beth Murphy and Ken Cooley

Retrieved on: 
Wednesday, February 14, 2024
Public Policy, Government, Insurance, State, Local, Consulting, Continuing, Professional Services, Education, Training, Personal injury lawyer, Public policy, Internal audit, EVP, Bell, University, Senate, Advisory Council, Council, JD, Grange Insurance, Employment, Policy, Privacy, National Council, Corporation, Joint, Management

The Institutes Griffith Foundation is pleased to announce the two newest members of its Advisory Council, Beth W. Murphy and Ken Cooley.

Key Points: 
  • The Institutes Griffith Foundation is pleased to announce the two newest members of its Advisory Council, Beth W. Murphy and Ken Cooley.
  • Both Murphy and Cooley will help to advance Griffith’s mission to provide non-partisan, non-advocative education to public policy members.
  • Beth Murphy , as EVP, Chief Legal Officer, and Corporate Secretary at Grange Insurance , leads the Legal, Compliance, Internal Audit, House Counsel, and Corporate Litigation teams.
  • As stated by The Institutes Griffith Foundation Executive Director, Frank Paul Tomasello, “It is a great pleasure to welcome Beth Murphy and Ken Cooley to the Advisory Council.

PETVIVO HOLDINGS, INC. TO EXHIBIT AT THE WESTERN VETERINARY CONFERENCE IN LAS VEGAS, NEVADA

Retrieved on: 
Tuesday, February 13, 2024
Pet, Osteoarthritis, Animal, Joint, Veterinarian, Conference, Arthralgia, WVC, Mandalay Bay Convention Center, Video game

PetVivo intends to exhibit its lead product, SPRYNG™ with OsteoCushion™ Technology, an intra-articular injectable veterinary medical device consisting of sterilized, extra-cellular matrix microparticles.

Key Points: 
  • PetVivo intends to exhibit its lead product, SPRYNG™ with OsteoCushion™ Technology, an intra-articular injectable veterinary medical device consisting of sterilized, extra-cellular matrix microparticles.
  • The microparticles of Spryng have been found to adsorb onto the joint synovial lining of animals and subsequently integrate with the animal’s subsynovial tissue.
  • WVC is the largest veterinary conference that services the western part of the United States, and normally plays host to more than 15,000+ participants including many of the top industry professionals.
  • “We are incredibly excited to participate in this year’s Western Veterinary Conference.

Verde Clean Fuels, Inc. and Cottonmouth Ventures LLC Announce Joint Development Agreement for a Proposed Natural Gas-to-Gasoline Facility in Permian Basin

Retrieved on: 
Tuesday, February 13, 2024
Oil, Gas, Alternative Energy, Energy, Other Energy, Utilities, Permian, FANG, Multimedia, Natural gas, Gasoline, Carbon, JDA, Fuel pump, Joint, Diamondback Energy, Heart, FID

Verde Clean Fuels, Inc. (NASDAQ: VGAS) (“Verde” or the “Company”) and Cottonmouth Ventures LLC, a subsidiary of Diamondback Energy (NASDAQ: FANG) (“Diamondback”), today announced that the parties have executed a Joint Development Agreement (“JDA”) for the proposed development, construction, and operation of a facility to produce commodity-grade gasoline utilizing associated natural gas feedstock supplied from Diamondback’s operations in the Permian Basin.

Key Points: 
  • Verde Clean Fuels, Inc. (NASDAQ: VGAS) (“Verde” or the “Company”) and Cottonmouth Ventures LLC, a subsidiary of Diamondback Energy (NASDAQ: FANG) (“Diamondback”), today announced that the parties have executed a Joint Development Agreement (“JDA”) for the proposed development, construction, and operation of a facility to produce commodity-grade gasoline utilizing associated natural gas feedstock supplied from Diamondback’s operations in the Permian Basin.
  • View the full release here: https://www.businesswire.com/news/home/20240213075887/en/
    The JDA provides a pathway forward for the parties to reach final definitive documents and Final Investment Decision (“FID") for the proposed project.
  • “The Verde Clean Fuels team is incredibly excited to finalize this JDA with Diamondback Energy with the goal to produce gasoline from natural gas in the Permian Basin,” said Ernie Miller, CEO of Verde.
  • “Additionally, the scalability of the project is incredibly exciting, with similar natural gas-to-gasoline facilities possible across Diamondback’s locations in West Texas.

The EBA publishes follow-up on the Peer Review on the Joint ESAs Guidelines on the prudential assessment of the acquisition of qualifying holdings

Retrieved on: 
Tuesday, February 13, 2024
Acquisition, EBA, Peer review, European, Particular, EEA, CAS, CRD, Joint

The EBA publishes follow-up on the Peer Review on the Joint ESAs Guidelines on the prudential assessment of the acquisition of qualifying holdings

Key Points: 
  • The EBA publishes follow-up on the Peer Review on the Joint ESAs Guidelines on the prudential assessment of the acquisition of qualifying holdings
    The European Banking Authority (EBA) today published a follow-up to the EBA 2021 peer review report on the application of the Joint ESAs Guidelines on the prudential assessment of the acquisition of qualifying holdings.
  • The follow-up report focuses on the 17 competent authorities assessed as having at least one supervisory benchmark which was not ‘fully applied’ in the 2021 Report.
  • All 17 CAs were found to have responded to the assessment of the initial peer review seriously and most have adopted measures to remedy the deficiencies identified.
  • The peer review has been performed by an ad hoc Peer Review Committee made up of EBA and competent authorities’ staff in accordance with the EBA peer review work plan for 2023-2024 and following the process in Article 30 of the EBA Regulation and EBA peer review methodology.

Novotech Publishes Candidiasis and Rheumatoid Arthritis Clinical Trial Landscape Reports to Support Biotech Research Planning

Retrieved on: 
Monday, February 12, 2024
Therapy, Woman, Compound annual growth rate, Gene editing, Rheumatoid arthritis, APA, MicroRNA, Research, Investment, Molecular medicine, Candida albicans, Epidemiology, Geography, Death, Prevalence, Lead, Contract research organization, Joint, Organization, SWOT analysis, Optimism, Clinical trial, Diagnosis, Fungal infection, Disease-modifying antirheumatic drug, Pharmaceutical industry

The Novotech research analyst team provides these expert reports on a monthly basis, completely free of charge.

Key Points: 
  • The Novotech research analyst team provides these expert reports on a monthly basis, completely free of charge.
  • These reports offer current insights into global clinical trial activity, revealing which regions experience the highest trial volumes and the factors behind these trends.
  • The Rheumatoid Arthritis (RA)– Global Clinical Trial Landscape report looks at the prevalence globally and identifies the key factors driving this condition.
  • Overall, this report provides vital insights into the global clinical trial landscape, detailing ongoing developments in RA research.

NATURE'S MIRACLE, INC. ANNOUNCES JOINT DEVELOPMENT OF "MIRACLEFARM" CONTAINER FARM UNITS WITH AFAFA

Retrieved on: 
Friday, February 9, 2024
Joint, Miracle, Public expenditure, Automation, Marketing, Research

LOS ANGELES, Feb. 9, 2024 /PRNewswire/ -- Nature's Miracle Holdings Inc. ("Nature's Miracle") has entered into a Joint Development Agreement with Afafa, Inc. ("AFAFA") to exclusively design, develop, manufacture and sell industry leading MiracleFarm "5+1" container farm units.

Key Points: 
  • LOS ANGELES, Feb. 9, 2024 /PRNewswire/ -- Nature's Miracle Holdings Inc. ("Nature's Miracle") has entered into a Joint Development Agreement with Afafa, Inc. ("AFAFA") to exclusively design, develop, manufacture and sell industry leading MiracleFarm "5+1" container farm units.
  • A MiracleFarm "5+1" container farm consists of five vegetable-growing 40-foot containers plus one container providing the controlling and seeding function.
  • Nature's Miracle will jointly develop MiracleFarm with AFAFA by investing in research, design of the product, material costing and final manufacturing processes of units.
  • Nature's Miracle is planning to launch our Miracle Farm "5+1" container farm units in North America in mid-2024.

NATURE'S MIRACLE, INC. ANNOUNCES JOINT DEVELOPMENT OF "MIRACLEFARM" CONTAINER FARM UNITS WITH AFAFA

Retrieved on: 
Friday, February 9, 2024
Joint, Miracle, Public expenditure, Automation, Marketing, Research

LOS ANGELES, Feb. 9, 2024 /PRNewswire/ -- Nature's Miracle Holdings Inc. ("Nature's Miracle") has entered into a Joint Development Agreement with Afafa, Inc. ("AFAFA") to exclusively design, develop, manufacture and sell industry leading MiracleFarm "5+1" container farm units.

Key Points: 
  • LOS ANGELES, Feb. 9, 2024 /PRNewswire/ -- Nature's Miracle Holdings Inc. ("Nature's Miracle") has entered into a Joint Development Agreement with Afafa, Inc. ("AFAFA") to exclusively design, develop, manufacture and sell industry leading MiracleFarm "5+1" container farm units.
  • A MiracleFarm "5+1" container farm consists of five vegetable-growing 40-foot containers plus one container providing the controlling and seeding function.
  • Nature's Miracle will jointly develop MiracleFarm with AFAFA by investing in research, design of the product, material costing and final manufacturing processes of units.
  • Nature's Miracle is planning to launch our Miracle Farm "5+1" container farm units in North America in mid-2024.